NBF-006

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNBF-006
Drug Alias NameNBF-006
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionGlutathione S-transferase Pi inhibitorsRNA interference
TargetsGlutathione S-transferase Pi
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNitto Denko
China Registration ClassN/A

Develop Information

Active CompaniesNitto Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A